NCT07590115

Brief Summary

Behavioral rigidity, the tendency to maintain inflexible patterns of thinking and acting despite changing circumstances, is a common feature in substance use disorders, depression, and anxiety. This observational study aims to measure behavioral rigidity as a dynamic, transdiagnostic process in patients undergoing residential treatment for substance use. Using a longitudinal intensive repeated-measures design, participants complete weekly assessments of cognitive reactivity (Automatic Thoughts Questionnaire-8 item version, ATQ-8), behavioral activation (Behavioral Activation for Depression Scale, BADS), and experiential avoidance. A Behavioral Rigidity Index (BRI) is derived from these measures. Additionally, natural language processing (NLP) is applied to therapy session transcripts to quantify linguistic absolutism (e.g., use of words like "always," "never") and affective polarity. Bayesian multilevel models examine whether rigidity predicts current and next-week clinical status. The study also explores whether linguistic markers add unique predictive value beyond self-reports. Results may inform personalized monitoring and interventions targeting psychological inflexibility in addiction treatment.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
1mo left

Started May 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
May 2025Jul 2026

Study Start

First participant enrolled

May 25, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2026

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

May 9, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 15, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

May 18, 2026

Status Verified

May 1, 2026

Enrollment Period

11 months

First QC Date

May 9, 2026

Last Update Submit

May 14, 2026

Conditions

Keywords

Behavioral rigiditySubstance use disorderTransdiagnosticLongitudinalNLPAbsolutismBayesian multilevelTherapeutic community

Outcome Measures

Primary Outcomes (1)

  • Change in negative automatic thoughts measured by the Automatic Thoughts Questionnaire 8-item version

    The Automatic Thoughts Questionnaire 8-item version is a self-report measure assessing the frequency of negative automatic thoughts. Total scores range from 8 to 40, with higher scores indicating more frequent negative automatic thoughts. Longitudinal change in total score across treatment is evaluated as the primary outcome.

    Weekly from baseline until discharge from treatment (up to 12 weeks)

Secondary Outcomes (5)

  • Behavioral Rigidity Index - Pondered (study-derived composite index)

    Weekly from baseline until discharge (up to 12 weeks)

  • Behavioral activation measured by the Behavioral Activation for Depression Scale Activation subscale

    Weekly from baseline until discharge (up to 12 weeks)

  • Avoidance and rumination measured by the Behavioral Activation for Depression Scale Avoidance/Rumination subscale

    Weekly from baseline until discharge (up to 12 weeks)

  • Linguistic Rigidity Index derived from therapy session transcripts

    Weekly from baseline until discharge (up to 12 weeks)

  • Change in anxiety symptoms measured by the Generalized Anxiety Disorder 7-item scale

    Weekly from baseline until discharge (up to 12 weeks)

Study Arms (1)

Participants with Substance Use Disorder

Adult patients (n=34) receiving standard residential treatment for substance use disorder in a therapeutic community. All participants undergo weekly assessments of cognitive reactivity (Automatic Thoughts Questionnaire-8 item version, ATQ-8), behavioral activation (Behavioral Activation for Depression Scale, BADS), and natural language processing (NLP) of therapy session transcripts.

Other: No intervention

Interventions

This is an observational study; no experimental intervention is administered. Participants continue their standard residential treatment as usual, which includes psychosocial therapy, 12-step facilitation, and occupational activities.

Participants with Substance Use Disorder

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Adult patients (age 18-60) with substance use disorder and co-occurring emotional dysregulation or behavioral maladaptation, admitted to a residential therapeutic community in Mexico. The sample includes both sexes, with an expected predominance of males (approximately 85%). Participants are receiving standard psychosocial treatment, including individual and group therapy, 12-step facilitation, and occupational activities. No healthy volunteers are included.

You may qualify if:

  • Minimum stay of four weeks in the residential treatment program
  • At least three complete longitudinal measurement time points
  • Ability to read, understand, and respond to self-report instruments in Spanish
  • Capacity to participate in structured clinical sessions
  • Diagnosis of substance use disorder (clinical assessment)

You may not qualify if:

  • Severe neurocognitive impairment
  • Acute psychotic symptoms
  • Incomplete longitudinal records (less than three time points)
  • Inability to complete self-report measures due to cognitive or language barriers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Under The Tree Potrerillos

Potrerillos, Jalisco, 45815, Mexico

Location

MeSH Terms

Conditions

Substance-Related DisordersAnxiety Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Study Officials

  • Lauro Gutiérrez Castro

    Under The Tree Therapeutic Community

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 9, 2026

First Posted

May 15, 2026

Study Start

May 25, 2025

Primary Completion

April 15, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

May 18, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations